Booster Vaccination to Reduce SARS-CoV-2 Transmission and Infection
Author:
Affiliation:
1. Department of Medicine, Epidemiology, and Laboratory Medicine & Pathology, University of Washington, Seattle
2. Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, Washington
Publisher
American Medical Association (AMA)
Subject
General Medicine
Link
https://jamanetwork.com/journals/jama/articlepdf/2788105/jama_wald_2022_ed_210098_1643049474.26893.pdf
Reference13 articles.
1. Long-term evolution of SARS-CoV-2 in an immunocompromised patient with non-Hodgkin lymphoma.;Borges;mSphere,2021
2. Association of a third dose of BNT162b2 vaccine with incidence of SARS-CoV-2 infection among health care workers in Israel.;Spitzer;JAMA,2022
3. Protection against Covid-19 by BNT162b2 booster across age groups.;Bar-On;N Engl J Med,2021
4. Booster and additional primary dose COVID-19 vaccinations among adults aged =65 years: United States, August 13, 2021-November 19, 2021.;Fast;MMWR Morb Mortal Wkly Rep,2021
5. Immunogenicity and reactogenicity of alternative schedules of HPV vaccine in Vietnam: a cluster randomized noninferiority trial.;Neuzil;JAMA,2011
Cited by 40 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Using cluster analysis to explore COVID-19 vaccine booster hesitancy by levels of medical mistrust in fully vaccinated US adults;Annals of Medicine;2024-09-11
2. National science foundation grant awardees’ perspectives on Article X and sexual harassment in science;PLOS ONE;2024-04-30
3. The continuance intention to vaccinate against COVID-19: An empirical study from Malaysia;PLOS ONE;2024-04-30
4. Factors influencing Thai university students’ decisions to take COVID-19 vaccine booster doses: a cross-sectional survey;Tropical Medicine and Health;2024-04-17
5. Comparative Pharmacological Efficacy of COVID-19 Vaccines against the Variants of Concerns (VOCs) of SARS-CoV-2: Recent Clinical Studies on Booster Dose;Current Pharmaceutical Biotechnology;2023-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3